Miaojin Zhou

531 citations
35 papers · 379 indexed · h-index 12
Topics
CRISPR and Genetic Engineering (20 papers)CAR-T cell therapy research (10 papers)Pluripotent Stem Cells Research (9 papers)
Partner nations
ChinaGermanyUkraine

In The Last Decade

Miaojin Zhou

35 papers receiving 376 citations

Peers

Miaojin Zhou
Comparison fields: 5 of 63
  • Molecular Biology 312
  • Genetics 59
  • Genetics 59
  • Oncology 51
  • Hematology 47
Replace Eric Kildebeck with:
Eric Kildebeck United States
Erica C. Jonlin United States
Julianne Rieders United States
David Yudovich Sweden
Sabina Sánchez-Hernández Spain
Cory Smith United States
Ngoc Tung Tran United States
Alisa Tubsuwan Thailand
Andriana G. Kotini United States
Eva Mejía-Ramírez Spain
Miaojin Zhou relative to Eric Kildebeck United States Eric Kildebeck's profile →
Citations per field
00.5×4.3×
Eric Kildebeck · 1×
Citations per year

Countries citing papers authored by Miaojin Zhou

Since Specialization
Citations

This map shows the geographic impact of Miaojin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miaojin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miaojin Zhou more than expected).

Fields of papers citing papers by Miaojin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miaojin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miaojin Zhou. The network helps show where Miaojin Zhou may publish in the future.

Co-authorship network of co-authors of Miaojin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Miaojin Zhou. A scholar is included among the top collaborators of Miaojin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miaojin Zhou. Miaojin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 5
3 10
4 2
5 4
6 7
7 3
8 3
9 17
10 4
11 6
12 11
13 6
14 8
15 4
16 5
17 53
18 3
19 28
20 22

About Miaojin Zhou

Miaojin Zhou is a scholar working on Genetics, Business and International Management and Molecular Biology, having authored 35 papers that have together received 379 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (20 papers), CAR-T cell therapy research (10 papers) and Pluripotent Stem Cells Research (9 papers). The work is most often cited by research in Business and International Management (17 citations), Aging (13 citations) and Genetics (59 citations). Miaojin Zhou has collaborated with scholars based in China, Germany and Ukraine. Frequent co-authors include Desheng Liang, Lingqian Wu, Zhiqing Hu, Xionghao Liu, Zhuo Li, Mai Feng, Yong Wu, Tao Zhou, Qian Hu and Zhuo Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026